Litcius/Paper detail

Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study

Cataldo Patruno, Gabriella Fabbrocini, G. Longo, Giuseppe Argenziano, Silvia Mariel Ferrucci, Luca Stingeni, Ketty Peris, Michela Ortoncelli, Annamaria Offidani, Giuseppe Fabrizio Amoruso, Marina Talamonti, Giampiero Girolomoni, Teresa Grieco, Michela Iannone, Eustachio Nettis, Caterina Foti, Franco Rongioletti, Monica Corazza, Michele Delli Veneri, Maddalena Napolitano, Dupilumab for Atopic Dermatitis of the Elderly (DADE) Study Group, Luisa Angileri, Tommaso Bianchelli, Alessandro Borghi, Giulia Calabrese, Camilla Chello, Giacomo Dal Bello, Stefano Dastoli, Maria Ferrillo, Marco Galluzzo, Niccolò Gori, Katharina Hansel, Luigi Macchia, Viviana Piras, Eugenio Provenzano, Simone Ribero, Marco Romanelli, Paolo Romita

2021American Journal of Clinical Dermatology57 citationsDOI

Topics & Concepts

MedicineAtopic dermatitisDupilumabEczema Area and Severity IndexDermatology Life Quality IndexObservational studyAdverse effectQuality of life (healthcare)DermatologyContraindicationInternal medicineSeverity of illnessRetrospective cohort studyDiseasePathologyAlternative medicineNursingDermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisAllergic Rhinitis and Sensitization
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study | Litcius